139 related articles for article (PubMed ID: 18501614)
21. Characterization of basolateral-targeting signals in the neonatal Fc receptor.
Newton EE; Wu Z; Simister NE
J Cell Sci; 2005 Jun; 118(Pt 11):2461-9. PubMed ID: 15923659
[TBL] [Abstract][Full Text] [Related]
22. High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization.
Vaughn DE; Bjorkman PJ
Biochemistry; 1997 Aug; 36(31):9374-80. PubMed ID: 9235980
[TBL] [Abstract][Full Text] [Related]
23. Quantitative methods for developing Fc mutants with extended half-lives.
Kamei DT; Lao BJ; Ricci MS; Deshpande R; Xu H; Tidor B; Lauffenburger DA
Biotechnol Bioeng; 2005 Dec; 92(6):748-60. PubMed ID: 16136591
[TBL] [Abstract][Full Text] [Related]
24. Development of new models for the analysis of Fc-FcRn interactions.
Gurbaxani BM; Morrison SL
Mol Immunol; 2006 Mar; 43(9):1379-89. PubMed ID: 16183124
[TBL] [Abstract][Full Text] [Related]
25. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,).
West AP; Bjorkman PJ
Biochemistry; 2000 Aug; 39(32):9698-708. PubMed ID: 10933786
[TBL] [Abstract][Full Text] [Related]
27. PEGylation enhances the therapeutic potential of peptide antagonists of the neonatal Fc receptor, FcRn.
Mezo AR; Low SC; Hoehn T; Palmieri H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6332-5. PubMed ID: 21920737
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.
Burmeister WP; Gastinel LN; Simister NE; Blum ML; Bjorkman PJ
Nature; 1994 Nov; 372(6504):336-43. PubMed ID: 7969491
[TBL] [Abstract][Full Text] [Related]
29. Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues.
Cianga C; Cianga P; Plamadeala P; Amalinei C
Hum Immunol; 2011 Dec; 72(12):1176-87. PubMed ID: 21978715
[TBL] [Abstract][Full Text] [Related]
30. FcRn: the neonatal Fc receptor comes of age.
Roopenian DC; Akilesh S
Nat Rev Immunol; 2007 Sep; 7(9):715-25. PubMed ID: 17703228
[TBL] [Abstract][Full Text] [Related]
31. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life.
Gurbaxani B; Dela Cruz LL; Chintalacharuvu K; Morrison SL
Mol Immunol; 2006 Mar; 43(9):1462-73. PubMed ID: 16139891
[TBL] [Abstract][Full Text] [Related]
32. Generation of mutated variants of the human form of the MHC class I-related receptor, FcRn, with increased affinity for mouse immunoglobulin G.
Zhou J; Johnson JE; Ghetie V; Ober RJ; Ward ES
J Mol Biol; 2003 Sep; 332(4):901-13. PubMed ID: 12972260
[TBL] [Abstract][Full Text] [Related]
33. FcRn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro FcRn binding properties in cynomolgus monkeys.
Datta-Mannan A; Chow CK; Dickinson C; Driver D; Lu J; Witcher DR; Wroblewski VJ
Drug Metab Dispos; 2012 Aug; 40(8):1545-55. PubMed ID: 22584253
[TBL] [Abstract][Full Text] [Related]
34. Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates.
Datta-Mannan A; Witcher DR; Tang Y; Watkins J; Jiang W; Wroblewski VJ
Drug Metab Dispos; 2007 Jan; 35(1):86-94. PubMed ID: 17050651
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of the FcRn:IgG protein-protein interaction.
Low SC; Mezo AR
AAPS J; 2009 Sep; 11(3):432-4. PubMed ID: 19499344
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of a human Fc fragment engineered for extended serum half-life.
Oganesyan V; Damschroder MM; Woods RM; Cook KE; Wu H; Dall'acqua WF
Mol Immunol; 2009 May; 46(8-9):1750-5. PubMed ID: 19250681
[TBL] [Abstract][Full Text] [Related]
37. Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis.
Zhou J; Mateos F; Ober RJ; Ward ES
J Mol Biol; 2005 Feb; 345(5):1071-81. PubMed ID: 15644205
[TBL] [Abstract][Full Text] [Related]
38. Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells.
Sato K; Nagai J; Mitsui N; Ryoko Yumoto ; Takano M
Life Sci; 2009 Dec; 85(23-26):800-7. PubMed ID: 19879882
[TBL] [Abstract][Full Text] [Related]
39. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc.
Huber AH; Kelley RF; Gastinel LN; Bjorkman PJ
J Mol Biol; 1993 Apr; 230(3):1077-83. PubMed ID: 8478919
[TBL] [Abstract][Full Text] [Related]
40. Human IgE does not bind to human FcRn.
Brinkhaus M; van der Kooi EJ; Bentlage AEH; Ooijevaar-de Heer P; Derksen NIL; Rispens T; Vidarsson G
Sci Rep; 2022 Jan; 12(1):62. PubMed ID: 34996950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
